The world’s first green laser
FDA market cleared for overall body circumference reduction
- No Downtime
- No Pain or Bruising
- No Freezing
- No Side-effects
Introducing EMERALD™ – A non-invasive low-level laser that emits 10 532 nm green lasers onto the skin to treat hypertrophic adipocytes.
The treatment emulsifies the adipose tissue and releases excess fatty materials into the interstitial space. From there, fat cells are passed through the body during its natural course of detoxification through the lymphatic system.
COLD LASER TECHONOLGY
Developed by Erchonia® the gold standard for low-level laser technology.
Why EMERALD™
-
Completely unattended treatments
Perform additional valuable treatments as EMERALD™ runs unattended safely
-
No side effects or downtime
Patients can resume their activities immediately following a treatment
-
Proven & measurable results
Average circumference loss of 6 inches *
-
Only FDA Approved low level laser
FDA market cleared to treat patients with a BMI of up to 40
-
Target multiple areas of the body
Including the abdomen, arms, back, hips, thighs, and lower leg
Watch how EMERALD™ works
Clinical testing ensures that a fat loss procedure is safe and effective. Erchonia’s green laser has undergone multiple clinical studies, so clients can have confidence that the treatment works with proven results.
The Results
Clinically Tested & FDA Cleared
Proven effective through level (1) clinical studies view studies
These trials and FDA Market-Clearances confirm that the Emerald™ procedure is safe. Since the Emerald laser™ helps you lose actual fat and not water weight, results are permanent as long as you stick to a calorie neutral diet after the treatments.
Talk to our experts today
If you want to book a demo, get in touch with us today
Erchonia is the world leader in low-level laser technology
Innovative Cold Laser Technology
During the procedure, fat cells are treated in a quick, safe, and effective manner. Emerald’s lasers penetrate the skin and make tiny pores in our fat cells, allowing excess fatty materials to be released into the interstitial space where it is passed through the body during its natural course of detoxification via the lymphatic system.
Results obtained will be long-lasting as long as patients stick to a calorie-neutral diet and remain hydrated proceeding the treatments
-
10 independent 532nm lasers
Allows for the treatment of multiple areas of the body, ensuring circumferential reduction in an effective manner -
Involves shrinking fat cells
As opposed to eliminating them, resulting in gradual weight loss with no accompanying side effects
Low Level Laser Clinical Studies
Low-Level Laser Therapy for Reducing the Hip, Waist, and Upper Abdomen Circumference of Individuals with Obesity
Photomedicine and Laser Surgery
Volume 35, Number 3, 2017
Gregory C. Roche, DO, Steven Shanks, Robert F. Jackson, MD, and Laura Jane Holsey, DO
A Double-Blind, Placebo-Controlled Randomized Trial Evaluating the Ability of Low-Level Laser Therapy to Improve the Appearance of Cellulite
Robert F. Jackson, MD, Gregory C. Roche, DO, and Steven Shanks
A Double-Blind, Sham-Controlled Study Demonstrating the Effectiveness of Low-Level Laser Therapy Using a 532-nm Green Diode for Contouring the Waist, Hips, and Thighs Abstract
David P. Suarez , DO; Gregory C. Roche , MD, FACS; Robert F. Jackson , MD, FACS
Fat Liquefaction: Effect of Low-Level Laser Energy on Adipose Tissue
Rodrigo Neira, M.D., Jose Arroyave, B.S.C.E., T.E.M., S.E.M., Hugo Ramierez, M.V., Clara Lucia Ortiz, M.D., Efrain Solarte, Dr. rer. nat. Federico Sequeda, Ph.D., and Maria Isabel Gutierrez, M.D., M.Se., Ph.D.
Fat Liquefaction: Effect of Low-Level Laser Energy on Adipose Tissue
Rodrigo Neira, M.D., Jose Arroyave, B.S.C.E., T.E.M., S.E.M., Hugo Ramierez, M.V., Clara Lucia Ortiz, M.D., Efrain Solarte, Dr. rer. nat. Federico Sequeda, Ph.D., and Maria Isabel Gutierrez, M.D., M.Se., Ph.D.
Low-Level Laser Therapy as a Non-Invasive Approach for Body Contouring: A Randomized, Controlled Study Lasers in Surgery Medicine 41: 799-809 (2009)
Robert F. Jackson, MD; Joug D. Dedo, MD; Greg C. Roche, MD; David I. Turok, and Ryan J. Maloney